Keiji Aoshima

An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation

Hidesaku Asakura, Yasuo Ontachi, Tomoe Mizutani et al. · Critical Care Medicine · 2001 · 86 citations

Medicine, Hematology, Clinical Pharmacology +16

Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation

Hidesaku Asakura, Yasuo Ontachi, Tomoe Mizutani et al. · European Journal Of Haematology · 2001 · 69 citations

Medicine, Hematology, Clinical Biochemistry +16

Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus

Eriko Morishita, Hidesaku Asakura, Hiroshi Jokaji et al. · Atherosclerosis · 1996 · 64 citations

Medicine, Endocrinology, Internal Medicine +12

Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers

Hidesaku Asakura, Hiroshi Jokaji, Mikako Saito et al. · Blood Coagulation & Fibrinolysis · 1994 · 56 citations

Medicine, Hematology, Pathology +17

Plasma Levels of Lipoprotein(a) Are Elevated in Patients with the Antiphospholipid Antibody Syndrome

Masahide Yamazaki, Hidesaku Asakura, Hiroshi Jokaji et al. · Thrombosis and Haemostasis · 1994 · 56 citations

Medicine, Hematology, Pathology +15